Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD—results from COSYCONET

Abstract Background MRproANP and COPAVP are prognostic markers for mortality in chronic obstructive pulmonary disease (COPD). Furthermore, these biomarkers predict mortality due to cardiovascular diseases, which are important prognostically determining comorbidities in patients with COPD. However, l...

Полное описание

Библиографические подробности

Главные авторы:	S. Fähndrich, C. Herr, S. Teuteberg, P. Alter, S. Söhler, D. Soriano, J. Classen, J. Adams, V. Weinhold, H. Watz, B. Waschki, T. Zeller, M. Eichenlaub, F. C. Trudzinski, J. D. Michels, A. Omlor, F. Seiler, I. Moneke, F. Biertz, D. Stolz, T. Welte, H. U. Kauczor, K. Kahnert, R. A. Jörres, C. F. Vogelmeier, R. Bals, the German COSYCONET Cohort
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2024-01-01
Серии:	Respiratory Research
Предметы:	COPD Mortality MRproADM COPAVP MRproANP Prospective multicenter cohort study
Online-ссылка:	https://doi.org/10.1186/s12931-024-02690-9
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!